Skip Navigation
Join Us! Volunteer Today for Rheumatoid Arthritis Studies.
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID is committed to advancing the understanding of how and why autoimmune diseases such as rheumatoid arthritis (RA) occur and to conduct clinical research studies to develop more effective treatment approaches and prevention strategies.

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis (ClinicalTrials.gov identifier NCT00837434)
The primary purpose of this study is to determine the effectiveness of two tumor necrosis factor (TNF) inhibitors, etanercept and adalimumab, on memory B lymphocytes (B cells) in the peripheral blood of participants with RA.

Read about Living with Arthritis by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

Last Updated March 09, 2012

Last Reviewed September 14, 2010